Is PFS a more relevant endpoint than OS in 1L HR+, HER2– MBC? A systematic literature review

Autor:	M. Thabane, A. Shor, David Chandiwana, Johan Baeck, Janina Barth, Anna Forsythe, G. Tremblay
Rok vydání:	2017
Předmět:	Oncology medicine.medical_specialty Systematic review business.industry Internal medicine medicine Hematology business
Zdroj:	Annals of Oncology. 28:v84
ISSN:	0923-7534
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::896c1c271f9f8c07a8e5a1a42efef77b https://doi.org/10.1093/annonc/mdx365.024 Zobrazit plný text záznamu